Notice of Intent - EMIT II Plus Amphetamine Assay 1L Sole-Source
Closed Special Notice Posted
- Solicitation number
- FA301626Q0096
- Agency
-
Air Education and Training Command
Air Force, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Place of performance
- Jbsa Lackland, Texas 78236, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The 502d Contracting Squadron at Joint Base San Antonio-Lackland intends to award a sole-source, firm-fixed-price five-year Blanket Purchase Agreement to Siemens Healthcare Diagnostics, Inc. for EMIT II Plus Amphetamines Assay 1L testing kits for the Air Force Drug Testing Laboratory, with responses to a capability notice due by July 20, 2026 at 11:00 AM CDT. The Air Force determined that Siemens' kit (part number 10445421) is the only product meeting AFDTL's validation requirements for accuracy and reliability as an adjunct screen for amphetamines; discontinuing use would require substantial capital investment in additional instrumentation and personnel. Market research and a January 2026 sources-sought on SAM.gov yielded only the manufacturer as a capable respondent. The laboratory processes approximately 750,000 urinalysis samples annually and requires the kit to screen presumptive positive specimens, reducing unnecessary confirmation testing from 1,388 to 402 annually and generating significant cost savings over the five-year period compared to uncontracted pricing. The Government will procure a maximum of 10 kits per year with delivery to JBSA-Lackland between 0730–1400 hours Monday through Friday, excluding federal holidays and designated command family days. Interested parties may submit narrative capability statements via email to christopher.maier.3@us.af.mil; this notice precedes solicitation and does not constitute a quote request.
Notice text
The 502d Contracting Squadron, Joint Base San Antonio-Lackland (JBSA-Lackland), TX intends to solicit and award a sole-source, firm-fixed-price, five-year purchase order to Siemens Healthcare Diagnostics, Inc, under the authority of RFO 6.103-1(a).
This requirement is for EMIT II Plus Amphetamines Assay testing kits for the Air Force Drug Testing Laboratory (AFDTL) at JBSA-Lackland, TX. This will be awarded as a Blanket Purchase Agreement (BPA) with a five (5) year ordering period.
Through market research and the AFDTL experience with various testing kits, the EMIT II Plus Amphetamines Assay testing kits is essential to the Government's requirements as no other product can meet the agency's needs without unacceptable schedule delays and duplication of cost. Siemens Healthcare Diagnostics, Inc. is the manufacturer of these testing kits.
This NOTICE OF INTENT is not a Solicitation, or Request for Quote. It's a Government notification intended to proceed with a Sole-Source. However, interested parties may submit a narrative describing their capabilities to fulfill the requirement via email to christopher.maier.3@us.af.mil no later than 20 July 2026 at 11:00 AM CDT. Please see the attachments for additional details.
Files
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| 7A21--Siemens UniPOC Licenses and Service | VA Technology Acquisition Center | No set-aside | |
| Notice of Intent to Sole Source – AB Sciex LLC | NIH Clinical Center | No set-aside | |
| J066--Azenta NitroStore System PM and Support Services | Veterans Integrated Service Network 4 | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity